Data as of Mar 14
| +0.23 / +0.84%|
The 6 analysts offering 12-month price forecasts for Sabra Health Care REIT Inc have a median target of 31.50, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +14.42% increase from the last price of 27.53.
The current consensus among 7 polled investment analysts is to Buy stock in Sabra Health Care REIT Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.